Determination of risk and treatment of complications of prematurity
CA 2429615 C · Owner: Children'S Medical Center Corporation · Inventors: Hellstroem, Ann; Smith, Lois
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
In one aspect of the present invention there is provided a method for determining the risk of developing a complication of preterm birth in a patient born before 40 weeks of gestation or weighing 10 % less than the average for the patient's gestational age. The method involves measuring serum IGF-I and/or IGF-I binding protein levels after birth of the patient to obtain an IGF-I or IGF binding protein level; and correlating said IGF-I or IGF-I binding protein level with an in utero baseline level of IGF-I binding protein based on gestational age matched mean levels in utero wherein an IGF-I or IGF-, I binding protein level below the mean gestational age in utero level indicates the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 13, 2001 and granted July 12, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 13, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 13, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.